United States Foods and Drug Administration (USFDA) approval has been gotten by Aurobindo Pharma for a generic drug that treats a chronic kidney disease on Wednesday.In an interview to CNBC-TV18,
Surajit Pal of Prabhudas Lilladher in an interview said, “It is a big achievement, more than the money it is about establishing their name in limited competition drug. As far as money is concerned, it all depends on how many competitors will come. Till December there will be hardly any.”
Also Read:
Curd is a magical ingredient for beauty and health
